Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Carlo Aul"'
Publikováno v:
Leukemia Research. 47:63-69
The role of bone marrow dysplastic erythroid precursors (EP) in both MDS and AML has been the subject of considerable debate over the past several decades. We have analyzed a large series of adults with MDS and focused on whether any% of EP identifie
Autor:
Florian Nolte, Lorenz Trümper, Detlef Haase, Tim H. Brümmendorf, Wolf-Karsten Hofmann, Reinhard Stauder, Friederike Braulke, Peter L. Greenberg, Marilyn L. Slovak, Katharina Götze, Uwe Platzbecker, Mar Mallo, Michael Pfeilstöcker, Heinz Tüchler, Christa Fonatsch, Thomas Nösslinger, Katayoon Shirneshan, Francesc Solé, Wolfgang R. Sperr, Kazuma Ohyashiki, Carlo Aul, Barbara Hildebrandt, Michael Lübbert, Michelle M. Le Beau, Catharina Müller-Thomas, Peter Valent, John M. Bennett, Ulrich Germing, Julie Schanz, Aristoteles Giagounidis
Publikováno v:
Haematologica. 100:205-213
International Prognostic Scoring Systems are used to determine the individual risk profile of myelodysplastic syndrome patients. For the assessment of International Prognostic Scoring Systems, an adequate chromosome banding analysis of the bone marro
Autor:
Aristoteles Giagounidis, Kathrin Nachtkamp, Ulrich Germing, Rainer Haas, Norbert Gattermann, Carlo Aul, John M. Bennett, Corinna Strupp, Barbara Hildebrandt
Publikováno v:
Leukemia research. 57
Based on centrally diagnosed 3528 patients in the Dusseldorf registry, we validated the new proposals for the classification of the MDS by the WHO working group: 256 patients were diagnosed as MDSSLD (7,3%), 978 MDSMLD (27,7%), 227 MDS RS SLD (6,4%);
Autor:
Georg Maschmeyer, W.-D. Ludwig, Hubert Serve, Leopold Balleisen, Peter Staib, Wolfgang E. Berdel, Christoph Schliemann, Karsten Spiekermann, Eckhard Thiel, Bernhard Wörmann, Th. Büchner, M Stelljes, Dennis Görlich, Carsten Müller-Tidow, Wolfgang Köpcke, Achim Heinecke, Susanne Schnittger, Aristoteles Giagounidis, Claudia Haferlach, Jan Braess, Andreas Grüneisen, Maria-Cristina Sauerland, Hartmut Eimermacher, Herbert Rasche, Wolfgang Kern, Robert Peter Gale, Wolfgang Hiddemann, Dietrich W. Beelen, A. Reichle, Carlo Aul, Ruediger Hehlmann, Utz Krug, Torsten Haferlach, Eva Lengfelder
Publikováno v:
Leukemia. 30(6)
We randomized 3375 adults with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome to test whether increasingly intensive chemotherapies assigned at study-entry and analyzed on an intent-to-treat basis improved outcomes
Autor:
Reinhard Stauder, Thomas Müller, Friedrich Wimazal, Thomas Nösslinger, Otto Krieger, Ulrich Germing, Detlef Haase, Barbara Hildebrandt, Julie Schanz, Michael Pfeilstöcker, Regina Kunzmann, Christian Steidl, Lorenz Trümper, Peter Valent, Carlo Aul, Christa Fonatsch, Andrea Kündgen, Michael Lübbert, Aristoteles Giagounidis
Publikováno v:
Blood. 110:4385-4395
We have generated a large, unique database that includes morphologic, clinical, cytogenetic, and follow-up data from 2124 patients with myelodysplastic syndromes (MDSs) at 4 institutions in Austria and 4 in Germany. Cytogenetic analyses were successf
Autor:
Franco Mandelli, Jean-Pierre Marie, Marco Vignetti, Petra Muus, Eva Hellström-Lindberg, Carlo Aul, Theo de Witte, Dominik Selleslag, Boris Labar, Roel Willemze, Sergio Amadori, Songuel Cakmak-Wollgast, Stefan Suciu, M. Oosterveld, Amin Belhabri, Augustin Ferrant, Ulrich Jehn, Ulrich Germing, Michel Delforge, Uwe Hess
Publikováno v:
Annals of Hematology, 94, 23-34
Annals of Hematology, 94, 1, pp. 23-34
Annals of Hematology, 94, 1, pp. 23-34
Item does not contain fulltext High-risk myelodysplastic syndrome (MDS) patients have usually a less favorable outcome after intensive treatment compared with de novo acute myeloid leukemia (AML) patients. This may reflect different disease-related a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e9247e73bc4dbe3500604306566e143
http://hdl.handle.net/2066/152735
http://hdl.handle.net/2066/152735
Autor:
Theo de Witte, Carlo Aul, Hans-Eckart Schaefer, Aristoteles Giagounidis, Stefan Suciu, Ulrich Germing, Pierre W. Wijermans, Michael Lübbert, Björn Rüter, Anne Hagemeijer, Helmut R. Salih, Uwe Platzbecker, Heiko Becker, Boris Labar, Karl-Heinz Pflüger, Arnold Ganser, Petra Muus, Valeria Fiaccadori, Frédéric Baron, Dominik Selleslag
Publikováno v:
Annals of Hematology, 94, 2003-13
Annals of Hematology, 94, 12, pp. 2003-13
Annals of Hematology, 94, 12, pp. 2003-13
Item does not contain fulltext In the European Organisation for Research and Treatment of Cancer (EORTC)/GMDSSG phase III trial 06011, we compared decitabine (15 mg/m(2) every 8 h for 3 days) with best supportive care (BSC) in patients >/=60 years wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf0e2e99d0769e6fa7568e3b05d3644
http://hdl.handle.net/2066/152103
http://hdl.handle.net/2066/152103
Autor:
Christa Fonatsch, Michael Lübbert, Andrea Kündgen, Corinna Strupp, Norbert Gattermann, Detlef Haase, Thomas Nösslinger, Otto Krieger, Reinhard Stauder, Christian Steidl, Carlo Aul, Michael Pfeilstöcker, Peter Valent, Ulrich Germing, Rainer Haas, Aristoteles Giagounidis, T Mueller, Barbara Hildebrandt
Publikováno v:
Leukemia. 19:2223-2231
The international prognostic scoring system (IPSS) is considered the gold standard for risk assessment in primary myelodysplastic syndromes (MDS). This score includes several prognostic factors except serum lactate dehydrogenase (LDH). We evaluated t
Autor:
Ulrich Steidl, Ali-Nuri Huenerlituerkoglu, Guido Kobbe, Carlo Aul, Barbara Hildebrandt, Roland Fenk, Martin Kropff, P. Schneider, Rainer Haas, Axel Heyll
Publikováno v:
British Journal of Haematology. 130:588-594
We conducted a randomised trial comparing an intensified versus a standard conditioning regimen for high-dose chemotherapy followed by autologous stem-cell transplantation in patients with multiple myeloma. In this study, 56 patients were randomly as
Autor:
M. Heinsch, Manuel Aivado, Brigitte Schlegelberger, Ludwig Wilkens, H Willems, Claudia Schoch, A.A.N. Giagounidis, Ulrich Germing, S Haase, Carlo Aul, Barbara Hildebrandt
Publikováno v:
Leukemia. 18:113-119
We analyzed data of 76 consecutive patients with myelodysplastic syndrome (MDS) and isolated del(5q) (n=66) or del(5q) plus one additional chromosomal abnormality (n=10) included in our MDS database over the last 26 years. The median age of our patie